JP2022116233A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022116233A5 JP2022116233A5 JP2022088172A JP2022088172A JP2022116233A5 JP 2022116233 A5 JP2022116233 A5 JP 2022116233A5 JP 2022088172 A JP2022088172 A JP 2022088172A JP 2022088172 A JP2022088172 A JP 2022088172A JP 2022116233 A5 JP2022116233 A5 JP 2022116233A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- transition metal
- metal catalyst
- protecting group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 8
- -1 cyano, hydroxy Chemical group 0.000 claims 5
- 239000003054 catalyst Substances 0.000 claims 4
- 229910052723 transition metal Inorganic materials 0.000 claims 4
- 150000003624 transition metals Chemical class 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical group [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 claims 2
- 125000005620 boronic acid group Chemical group 0.000 claims 2
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000012391 XPhos Pd G2 Substances 0.000 claims 1
- 238000010306 acid treatment Methods 0.000 claims 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- RSLSVURFMXHEEU-UHFFFAOYSA-M chloropalladium(1+);dicyclohexyl-[3-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane;2-phenylaniline Chemical compound [Pd+]Cl.NC1=CC=CC=C1C1=CC=CC=[C-]1.CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC(P(C2CCCCC2)C2CCCCC2)=C1 RSLSVURFMXHEEU-UHFFFAOYSA-M 0.000 claims 1
- 150000002009 diols Chemical class 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 229910000160 potassium phosphate Inorganic materials 0.000 claims 1
- 235000011009 potassium phosphates Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- UGOMMVLRQDMAQQ-UHFFFAOYSA-N xphos Chemical group CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 UGOMMVLRQDMAQQ-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17168027 | 2017-04-25 | ||
| EP17168027.5 | 2017-04-25 | ||
| PCT/EP2018/060489 WO2018197503A1 (en) | 2017-04-25 | 2018-04-24 | Fused pentacyclic imidazole derivatives as modulators of tnf activity |
| JP2019556874A JP7083358B2 (ja) | 2017-04-25 | 2018-04-24 | Ｔｎｆ活性のモジュレーターとしての縮合五環式イミダゾール誘導体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019556874A Division JP7083358B2 (ja) | 2017-04-25 | 2018-04-24 | Ｔｎｆ活性のモジュレーターとしての縮合五環式イミダゾール誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022116233A JP2022116233A (ja) | 2022-08-09 |
| JP2022116233A5 true JP2022116233A5 (https=) | 2023-02-03 |
| JP7299382B2 JP7299382B2 (ja) | 2023-06-27 |
Family
ID=58632834
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019556874A Active JP7083358B2 (ja) | 2017-04-25 | 2018-04-24 | Ｔｎｆ活性のモジュレーターとしての縮合五環式イミダゾール誘導体 |
| JP2022088172A Active JP7299382B2 (ja) | 2017-04-25 | 2022-05-31 | Ｔｎｆ活性のモジュレーターとしての縮合五環式イミダゾール誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019556874A Active JP7083358B2 (ja) | 2017-04-25 | 2018-04-24 | Ｔｎｆ活性のモジュレーターとしての縮合五環式イミダゾール誘導体 |
Country Status (33)
| Country | Link |
|---|---|
| US (4) | US10980814B2 (https=) |
| EP (2) | EP3615534B1 (https=) |
| JP (2) | JP7083358B2 (https=) |
| KR (1) | KR102565132B1 (https=) |
| CN (1) | CN110582495B (https=) |
| AR (1) | AR111426A1 (https=) |
| AU (1) | AU2018259040B2 (https=) |
| CA (1) | CA3058980A1 (https=) |
| CL (1) | CL2019002875A1 (https=) |
| CO (1) | CO2019012856A2 (https=) |
| CR (1) | CR20190526A (https=) |
| DK (1) | DK3615534T3 (https=) |
| EA (1) | EA039049B1 (https=) |
| ES (2) | ES2893807T3 (https=) |
| HR (1) | HRP20211927T1 (https=) |
| HU (1) | HUE056593T2 (https=) |
| IL (1) | IL269890B (https=) |
| LT (1) | LT3615534T (https=) |
| MA (2) | MA49055B1 (https=) |
| MX (1) | MX2019012443A (https=) |
| MY (1) | MY197212A (https=) |
| PE (1) | PE20200662A1 (https=) |
| PH (1) | PH12019502182B1 (https=) |
| PL (2) | PL3939980T3 (https=) |
| PT (2) | PT3939980T (https=) |
| PY (1) | PY1829804A (https=) |
| RS (1) | RS62596B1 (https=) |
| SG (1) | SG11201908871SA (https=) |
| SI (1) | SI3615534T1 (https=) |
| TW (1) | TWI801378B (https=) |
| UY (1) | UY37700A (https=) |
| WO (1) | WO2018197503A1 (https=) |
| ZA (1) | ZA201906255B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10766906B2 (en) * | 2016-04-01 | 2020-09-08 | UCB Biopharma SRL | Fused hexacyclic imidazole derivatives as modulators of TNF activity |
| WO2018119142A1 (en) | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| CA3117344A1 (en) * | 2018-10-24 | 2020-04-30 | UCB Biopharma SRL | Fused pentacyclic imidazole derivatives as modulators of tnf activity |
| CN120418259A (zh) | 2022-11-23 | 2025-08-01 | 弗沃德医疗公司 | TNFα活性的调节剂 |
| TW202508596A (zh) | 2023-04-26 | 2025-03-01 | 法商賽諾菲公司 | 使用腫瘤壞死因子α之小分子抑制劑治療乾癬 |
| WO2024251282A1 (zh) * | 2023-06-09 | 2024-12-12 | 上海翰森生物医药科技有限公司 | 五环类衍生物抑制剂、其制备方法和应用 |
| TW202519231A (zh) | 2023-07-04 | 2025-05-16 | 法商賽諾菲公司 | 結晶形式 |
| TW202521544A (zh) | 2023-08-16 | 2025-06-01 | 美商雷瑟拉股份有限公司 | TNFα活性調節劑及其用途 |
| WO2025068505A1 (en) | 2023-09-29 | 2025-04-03 | Sanofi | Preparation of bridged pentacyclic imidazole derivatives as modulators of tnf activity, intermeditates and their preparation |
| TW202602881A (zh) * | 2024-03-27 | 2026-01-16 | 大陸商海思科醫藥集團股份有限公司 | 雜環衍生物及其在醫藥上的應用 |
| WO2025212627A1 (en) | 2024-04-03 | 2025-10-09 | Forward Therapeutics, Inc. | Modulators of tnf-alpha activity |
| WO2025218735A1 (zh) * | 2024-04-17 | 2025-10-23 | 上海翰森生物医药科技有限公司 | 五环类衍生物抑制剂、其制备方法和应用 |
| WO2025247401A1 (zh) * | 2024-05-31 | 2025-12-04 | 海思科医药集团股份有限公司 | 一种稠合杂环衍生物及其在医药上的应用 |
| WO2025252251A1 (zh) * | 2024-06-07 | 2025-12-11 | 上海翰森生物医药科技有限公司 | 含氧杂环类衍生物抑制剂、其制备方法和应用 |
| WO2026012303A1 (en) * | 2024-07-09 | 2026-01-15 | Hangzhou Highlightll Pharmaceutical Co., Ltd | NOVEL BENZO [4, 5] IMIDAZO COMPOUNDS AS TNFα MODULATORS |
| WO2026022134A1 (en) | 2024-07-23 | 2026-01-29 | Sanofi | Novel aminocarbonylation processes |
| WO2026021586A1 (zh) * | 2024-07-26 | 2026-01-29 | 上海瀚辰星泰医药科技有限公司 | 一种多环化合物及其制备方法和应用 |
| WO2026027449A1 (en) | 2024-07-29 | 2026-02-05 | Sanofi | Fused pentacyclic imidazole derivatives |
| WO2026051930A1 (zh) * | 2024-09-04 | 2026-03-12 | 苏州湃玥生物科技有限公司 | 一种作为tnf活性调节剂的稠合五环苯并咪唑衍生物及其制备方法和应用 |
| WO2026055519A1 (en) | 2024-09-06 | 2026-03-12 | Rapt Therapeutics, Inc. | Fused ring imidazole compounds |
| WO2026064602A1 (en) * | 2024-09-23 | 2026-03-26 | Synnovation Therapeutics, Inc. | HETEROCYCLIC COMPOUNDS AS MODULATORS OF TNFα ACTIVITY |
| WO2026068677A1 (en) | 2024-09-27 | 2026-04-02 | Sanofi | Processes for the preparation of fused pentacyclic imidazoles and intermediates |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9550737B2 (en) * | 2012-06-11 | 2017-01-24 | Ucb Biopharma Sprl | TNF -α modulating benzimidazoles |
| GB201212513D0 (en) * | 2012-07-13 | 2012-08-29 | Ucb Pharma Sa | Therapeutic agents |
| CN104619709B (zh) * | 2012-07-13 | 2016-11-09 | Ucb生物制药私人有限公司 | 作为tnf活性调节剂的咪唑并吡啶衍生物 |
| GB201321728D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| MX380578B (es) * | 2014-10-03 | 2025-03-12 | Ucb Biopharma Sprl | Derivados de imidazol pentaciclicos fusionados. |
| EP3288939A1 (en) * | 2015-04-17 | 2018-03-07 | AbbVie Inc. | Tricyclic modulators of tnf signaling |
-
2018
- 2018-04-24 AU AU2018259040A patent/AU2018259040B2/en active Active
- 2018-04-24 CN CN201880025894.6A patent/CN110582495B/zh active Active
- 2018-04-24 CA CA3058980A patent/CA3058980A1/en active Pending
- 2018-04-24 EP EP18719178.8A patent/EP3615534B1/en active Active
- 2018-04-24 MX MX2019012443A patent/MX2019012443A/es unknown
- 2018-04-24 SI SI201830491T patent/SI3615534T1/sl unknown
- 2018-04-24 HR HRP20211927TT patent/HRP20211927T1/hr unknown
- 2018-04-24 SG SG11201908871S patent/SG11201908871SA/en unknown
- 2018-04-24 HU HUE18719178A patent/HUE056593T2/hu unknown
- 2018-04-24 PL PL21189378.9T patent/PL3939980T3/pl unknown
- 2018-04-24 CR CR20190526A patent/CR20190526A/es unknown
- 2018-04-24 ES ES18719178T patent/ES2893807T3/es active Active
- 2018-04-24 PH PH1/2019/502182A patent/PH12019502182B1/en unknown
- 2018-04-24 MY MYPI2019005903A patent/MY197212A/en unknown
- 2018-04-24 EP EP21189378.9A patent/EP3939980B1/en active Active
- 2018-04-24 LT LTEPPCT/EP2018/060489T patent/LT3615534T/lt unknown
- 2018-04-24 RS RS20211403A patent/RS62596B1/sr unknown
- 2018-04-24 ES ES21189378T patent/ES2956555T3/es active Active
- 2018-04-24 JP JP2019556874A patent/JP7083358B2/ja active Active
- 2018-04-24 TW TW107113777A patent/TWI801378B/zh active
- 2018-04-24 MA MA49055A patent/MA49055B1/fr unknown
- 2018-04-24 PT PT211893789T patent/PT3939980T/pt unknown
- 2018-04-24 DK DK18719178.8T patent/DK3615534T3/da active
- 2018-04-24 PE PE2019002028A patent/PE20200662A1/es unknown
- 2018-04-24 PT PT187191788T patent/PT3615534T/pt unknown
- 2018-04-24 PL PL18719178T patent/PL3615534T3/pl unknown
- 2018-04-24 EA EA201992407A patent/EA039049B1/ru unknown
- 2018-04-24 WO PCT/EP2018/060489 patent/WO2018197503A1/en not_active Ceased
- 2018-04-24 US US16/497,217 patent/US10980814B2/en active Active
- 2018-04-24 KR KR1020197034032A patent/KR102565132B1/ko active Active
- 2018-04-25 AR ARP180101067A patent/AR111426A1/es active IP Right Grant
- 2018-04-25 PY PY201801829804A patent/PY1829804A/es unknown
- 2018-04-25 UY UY0001037700A patent/UY37700A/es not_active Application Discontinuation
- 2018-08-24 MA MA57699A patent/MA57699B1/fr unknown
-
2019
- 2019-09-20 ZA ZA2019/06255A patent/ZA201906255B/en unknown
- 2019-10-07 IL IL269890A patent/IL269890B/en unknown
- 2019-10-09 CL CL2019002875A patent/CL2019002875A1/es unknown
- 2019-11-18 CO CONC2019/0012856A patent/CO2019012856A2/es unknown
-
2021
- 2021-02-15 US US17/176,018 patent/US20210252012A1/en not_active Abandoned
-
2022
- 2022-05-31 JP JP2022088172A patent/JP7299382B2/ja active Active
-
2023
- 2023-02-27 US US18/175,030 patent/US20230250105A1/en not_active Abandoned
-
2024
- 2024-08-29 US US18/819,527 patent/US20250127795A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022116233A5 (https=) | ||
| JP2016512823A5 (https=) | ||
| JP2010513494A5 (https=) | ||
| JP2010174033A5 (https=) | ||
| CN103562170B (zh) | 经由克莱森重排制备双环化合物的方法 | |
| JP2013047248A (ja) | インテグラーゼ阻害剤を調製するためのプロセスおよび中間体 | |
| WO2017201846A1 (zh) | 一种噁唑烷酮类抗菌药物及其中间体的制备方法 | |
| WO2016041508A1 (zh) | 一种噁唑烷酮类化合物及其中间体的制备方法 | |
| JP4048119B2 (ja) | ２−（４−クロロベンゾイルアミノ）−３−［２（１ｈ）−キノールリノン−４−イル］プロピオン酸の製造方法 | |
| JP2013170151A (ja) | インドール‐３−トリフロン類の直接的製造法及びインドールトリフロン誘導体 | |
| CN1582272A (zh) | 制备5－(3－氰基苯基)－3－甲酰基苯甲酸化合物的方法 | |
| CN1671665A (zh) | 用于制备5－(2′－吡啶基)－2－吡啶酮衍生物的方法 | |
| CN101607971B (zh) | 9-[2-(二乙氧基膦酰甲氧基)乙基]腺嘌呤的合成方法 | |
| JP2018506541A5 (https=) | ||
| CN103508948A (zh) | 一种匹伐他汀钙的制备方法 | |
| CN114573512A (zh) | 一种合成c2-二氟烷基苯并咪唑衍生物的方法 | |
| CN111747975B (zh) | 贝达喹啉消旋体及其中间体的制备方法 | |
| JP2010043053A (ja) | 高純度のレバミピドの製造方法 | |
| CN1061778A (zh) | 氨基二醇衍生物 | |
| CN105085357B (zh) | 小构树碱类化合物及其制备方法和应用 | |
| CN111620788B (zh) | 一种制备(2s,3s)-3-氨基-二环[2.2.2]辛烷-2-甲酸酯的方法 | |
| CN102584668A (zh) | 一种2,3-二溴-5-苯甲酰吡咯的制备方法 | |
| CN103387547A (zh) | 一种制备嘧螨胺的方法 | |
| CN109293508B (zh) | 一种恩替卡韦中间体的制备方法 | |
| CN101066987A (zh) | 溴呋啶的制备方法 |